ASSESSMENT OF ADHERENCE TO 6- MERCAPTOPURINE IN MAINTENANCE PHASE  CHEMOTHERAPY IN CHILDREN WITH ACUTE  LYMPHOBLASTIC LEUKEMIA- A PROSPECTIVE  INTERVENTIONAL STUDY

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1565

Full metadata record

DC Field	Value	Language
dc.contributor.author	REGNO:BM0120004	-
dc.date.accessioned	2023-12-11T10:19:19Z	-
dc.date.available	2023-12-11T10:19:19Z	-
dc.date.issued	2023	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1565	-
dc.description.abstract	Background and aims 6 mercaptopurine (MP) forms backbone of maintenance chemotherapy for ALL, which typically lasts for 2 to 2.5 years. As with any long-term therapy, poor adherence is serious impediment in 6 MP maintenance treatment, which may impact outcome. Indeed, COG study found 3.9 fold increased risk of relapse in children with 6 MP adherence of less than 90%. There are no studies regarding adherence to 6MP from India. Hence, we studied prevalence of non- adherence to 6 MP and impact of use of electronic pill box on it, in our cohort on maintenance chemotherapy	en_US
dc.language.iso	en_US	en_US
dc.publisher	KLE Academy of Higher Education and Research, Belagavi	en_US
dc.title	ASSESSMENT OF ADHERENCE TO 6- MERCAPTOPURINE IN MAINTENANCE PHASE CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA- A PROSPECTIVE INTERVENTIONAL STUDY	en_US
dc.type	Dissertations	en_US
Appears in Collections:	Pediatrics MD

Files in This Item:

File	Description	Size	Format
BM0120004.pdf		2.1 MB	Adobe PDF	View/Open